Hamid Borghei Razavi, MD

• Director of Minimally Invasive Cranial and Pituitary Surgery Program, Cleveland Clinic Florida
• Research director, Neuroscience Institute, Cleveland Clinic Florida Region 
• Associate Professor of Neurological Surgery, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
• Associate program director, Skull Base Surgery Fellowship, Cleveland Clinic Florida
• Scientific Advisory Board member, Florida Center for Brain Tumor Research (FCBTR)
• Cranial Base Section Editor, World Neurosurgery Journal, Elsevier

• Doctor of Medicine, University of Lübeck, Germany, 2014 

• Fellow of American College of Surgeons (FACS), 10/2023
• Scientific and Research Committee member, North American Skull Base Society (NASBS), 2022-2024
• Chair of Pituitary Education Day, North American Skull Base Society (NASBS), 2/2024
• Chair of Kawase Education Day, North American Skull Base Society (NASBS), 2/2023
• Scientific Advisory Board member, Florida Center for Brain Tumor Research (FCBTR), 05/2020
• KARL STORZ Endoscopy-America MIS Lab Grant, 02/2020
• Fellow of the European Board of Neurological Surgery (FEBNS), 03/2018
• Poster of Distinction Award; 27th Annual Meeting of North American Skull Base Society, New Orleans, Louisiana, 03/2017
• Rolf Dierichs Research Grant; Münster, Germany, 04/2014
• Karl-Storz Scholarship; German Soc. Skull Base Surgery, 10/2013
• Carls-Zeiss German-Japan Exchange Program Scholarship; German Soc. Neurosurgery & Dept. Neurosurgery and Skull Base Surgery, Keio University, Tokyo, Japan, 05/2013
• Karl-Storz Fellowship Award; 6th Intl. Congress of the World Federation of Skull Base Societies/10th European Skull Base Society Congress, Brighton, England, 05/2012

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2025-12-08, Dr. Borghei Razavi has reported no financial relationship with industry that is applicable to this listing.

In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.